GGrantIndex
Sort

261,768 grants matching gene therapy

The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/Penn

$1,380,976
Robert Thomas Schultz · Children'S Hosp Of Philadelphia · P50 · FY2023 · HD

Center for Latino Health Research Opportunities-CLaRO

$1,380,867
Victoria B Mitrani · University Of Miami Coral Gables · U54 · FY2018 · MD

Immune Reconstitution

$1,380,789
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Transplant Models

$1,380,789
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Clinical production of viral vectors for cancer gene therapy

$1,380,777
Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA

A Vaccine for Schistosomiasis, "SchistoShield"

$1,380,664
Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2017 · AI

Spatial Imaging Technology Resource

$1,380,624
Mariam Malik · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Assessment, Therapy and Prevention Of Autoimmune Disease

$1,380,605
Lisa Rider · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES

Novel Therapeutics for Class B Protozoa

$1,380,550
Sharon L Reed · University Of California, San Diego · U01 · FY2010 · AI

NADPH Oxidases as Novel Targets for Cancer Therapy

$1,380,509
James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific Neuropharmacology

$1,380,473
Michael R Tadross · Duke University · R01 · FY2025 · MH

Microparticle Therapy for Cerebral Amyloid Angiopathy

$1,380,461
Wolff M. Kirsch · Karamedica, Inc. · R44 · FY2020 · AG

Genetic Modifiers of Initiation and Progression of Mammary Cancer

$1,380,348
Kent W Hunter · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia

$1,380,330
Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R33 · FY2024 · HL

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

$1,380,310
Daniel Woo · University Of Cincinnati · U01 · FY2017 · NS

Immunovascular interactions in postoperative delirium superimposed on dementia (DSD).

$1,380,185
Niccolo Terrando · Duke University · RF1 · FY2025 · AG

The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/Penn

$1,380,120
Robert Thomas Schultz · Children'S Hosp Of Philadelphia · P50 · FY2024 · HD

Citalopram Treatment for Agitation in Alzheimer Dementia

$1,379,758
Constantine G Lyketsos · Johns Hopkins University · R01 · FY2011 · AG

Novel Strategies for Brain Tumor Therapy

$1,379,728
University Of Pittsburgh At Pittsburgh · P01 · FY2004 · NS

CuRrEnT: Capecitabine in RCB2/3 with a wearable induced Electric field device in Triple Negative Breast Cancer

$1,379,442
Christopher Barron · Embiosys Inc. · R44 · FY2025 · CA

Immunobiology, molecular virology and countermeasures of highly pathogenic viruses

$1,379,371
Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Characterization of novel regulators of self-renewal and pluripotency

$1,379,366
Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction Treatment

$1,379,360
Roger Brooks Bagwell · Actuated Medical, Inc. · R44 · FY2025 · AA

A Molecular and Cellular Atlas of the Marmoset Brain

$1,379,324
Guoping Feng · Massachusetts Institute Of Technology · U01 · FY2017 · MH

The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/Penn

$1,379,212
Robert Thomas Schultz · Children'S Hosp Of Philadelphia · P50 · FY2025 · HD